Skip to main content
Engineering Mycoplasma pneumoniae as a broad-spectrum animal vaccine
PULMOBIOTICS: using synthetic biology to treat lung diseases
27 Apr 2020
The MycoSynVac project has ended on 31st March 2020, but it will leave different long-lasting marks. One example is the creation of a spin-off company from CRG called Pulmobiotics. ...
MycoSynVac the documentary